Vaccine for advanced breast or esophageal cancer
Part of Cancer, Digestive system, Skin clinical trials.
This trial tests a vaccine that targets HER2 protein on cancer cells. It is for people with advanced breast or esophageal cancer whose tumors have certain markers. The vaccine may help your immune system fight the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have breast or esophageal cancer that has spread or cannot be removed with surgery.
- Your tumor must test positive for HER2 or EGFR markers.
- You must have received or refused standard first-line treatment for your advanced cancer.
- If you have had brain metastases, they must be stable for at least 3 months and you must be off steroids.
- You must be at least 18 years old and have adequate organ function.
- You must not have active infections, autoimmune diseases, or certain other serious conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a vaccine designed to help the immune system fight remaining HER2-positive breast cancer cells after standard treatment. It is for people who have completed at least six months of HER2-targeted therapy and still have a high risk of the cancer coming back.
This trial tests an investigational vaccine called ConvitVax for people with advanced or metastatic breast cancer that has not responded to standard treatments. The vaccine is designed to help your immune system fight the cancer.
This Phase 2 study tests a personalized immune-therapy vaccine made from your immune cells, given with weekly paclitaxel and HER2-targeted antibodies (trastuzumab and pertuzumab). It aims to improve treatment outcomes for people with HER2-positive breast cancer before standard local treatment (like surgery and radiation).
This trial tests a personalized vaccine made from your own immune cells to help your body fight advanced breast cancer. It's for people with a specific genetic marker and whose cancer has not responded to standard treatments.
This trial tests a vaccine (STEMVAC) given with your standard hormone therapy or chemotherapy. It is for people with advanced hormone receptor-positive, HER2-negative breast cancer who are already on certain treatments. The goal is to see if adding the vaccine can help control the cancer better.
This trial tests a vaccine (MV-s-NAP) that is injected directly into a tumor to stimulate your immune system against breast cancer. It is for people with metastatic breast cancer that has spread despite prior treatments.
Hear when a new Metastatic Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.